Brandinium

Trademark search for:

EVASENSE

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2010-06-19 — Application filed
  • 2010-10-14 — Sn assigned for sect 66a appl from ib
  • 2010-10-15 — Application filed
  • 2010-10-15 — Assigned to examiner
  • 2010-10-19 — Application filed
  • 2010-10-20 — Approved for pub - principal register
  • 2010-11-03 — Assigned to lie
  • 2010-11-03 — Law office publication review completed
  • 2010-11-17 — Notice of publication
  • 2010-12-02 — Attorney/dom.rep.revoked and/or appointed
  • 2010-12-02 — Teas revoke/app/change addr of atty/dom rep received
  • 2010-12-07 — Published for opposition
  • 2011-02-22 — Registered-principal register
  • 2011-03-24 — Grant of protection created, to be sent to ib
  • 2011-04-27 — Final disposition recorded
  • 2011-04-27 — Final disposition recorded
  • 2011-06-03 — Notification processed by ib
  • 2013-10-11 — Teas change of correspondence received
  • 2016-02-22 — Courtesy reminder - sec. 71 (6-yr) e-mailed
  • 2016-08-04 — New representative at ib received
  • 2017-09-29 — Cancelled section 71
  • 2018-05-29 — Total invalidation of reg ext protection created
  • 2018-06-07 — Total invalidation of reg ext protection sent to ib
  • 2018-06-07 — Invalidation processed
  • 2018-09-14 — Total invalidation processed by the ib
  • 2020-06-19 — Final status recorded
  • 2021-07-10 — Death of international registration
  • 2021-07-10 — Notification of effect of cancellation of intl reg e-mailed

Owner Information

Affymax Pharma Limited
London EC2A 2RS GB
Affymax Pharma Limited
London EC2A 2RS GB
Affymax Pharma Limited
London EC2A 2RS GB

Correspondent

Anne H. Peck, COOLEY LLP
1299 Pennsylvania Avenue NW, Suite 700
WASHINGTON, DC 20004
UNITED STATES

Filing Details

Filing Date:
2010-06-19
Status Date:
2020-06-19
Category:
Pharmaceuticals
Filing Year:
2010

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.